References
- Jasani B, Weisz DE, McNamara PJ. Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants. Semin Perinatol 2018; 42(4):243–52.
- De Klerk JC, Engbers AG, Van Beek F, et al. Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review. Front Pediatr 2020; 8:541.
- Fink D, Nitzan I, Bin-Nun A, et al. Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates. J Perinatol 2018; 38(11):1526–31.
- Hundscheid T, Onland W, Overmeire B Van, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr 2018; 18:262. doi: 10.1186/s12887-018-1215-7
- Faim DRO, Tiago JAM, Castelo RJS, et al. Patent ductus arteriosus closure: Experience from a tertiary referral center. Rev Paul Pediatr 2020; 39:e2020013. doi: 10.1590/1984-0462/2021/39/2020013
- El-Mashad AE, El-Mahdy H, Amrousy D El, et al. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr 2017; 176:233–40. doi: 10.1007/s00431-016-2830-7
- Bardanzellu F, Neroni P, Dessì A, et al. Paracetamol in patent ductus arteriosus treatment: efficacious and safe? Biomed Res Int 2017; 2017:1438038. doi: 10.1155/2017/1438038.
- Al-lawama M, Alammori I, Abdelghani T, et al. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. J Int Med Res 2018; 46:811–8. doi: 10.1177/0300060517722698
- Yang B, Gao X, Ren Y, et al. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med 2016; 12:2531–6. doi: 10.3892/etm.2016.3676
- Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE 2013; 8:e77888. doi: 10.1371/journal.pone.0077888
- Karabulut B, Paytoncu S. Efficacy and safety of oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants. Pediatr Drugs 2019; 21:113–21.
- Nemerofsky SL, Parravicini E, Bateman D, et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol 2008; 25:661–6.
- Vaidya R, Knee A, Paris Y, et al. Predictors of successful patent ductus arteriosus closure with acetaminophen in preterm infants. J Perinatol 2021; 41(5):998–1006.
- Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev 2018; (4).
- Aikio O, Harkin P, Saarela T, et al. Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J Matern-Fetal Neonatal Med 2014; 27(12):1252–6.
- Terrin G, Conte F, Oncel MY, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: A systematic review and metaanalysis. Arch Dis Child: Fetal Neonatal Ed 2016; 101(2):F127–36.
- Höck M, Brunner B, Rier V, et al. Prophylactic low-dose paracetamol administration associated with lowered rate of patent ductus arteriosus in preterm infants: Impact on outcome and pain perception. Pediatr Neonatol 2020; 61(1):84–91.
- Dash SK, Kabra NS, Avasthi BS, et al. Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: A randomized controlled trial. Indian Pediatr 2015; 52(7):573–8. doi: 10.1007/s13312-015-0677-z
- Härkin P, Härmä A, Aikio O, et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: A randomized trial. J Pediatr 2016; 177:72–7.
- Bagheri MM, Bahman-Bijari B, Torabi-Nejad MH, et al. Is prophylactic parenteral paracetamol effective to diminish incidence of PDA in preterm neonates? A randomized trial. Iran J Pediatr 2018; 28(4).
- Schindler T, Smyth J, Bolisetty S, et al. Early Paracetamol (EPAR) trial: A randomized controlled trial of early paracetamol to promote closure of the ductus arteriosus in preterm infants. Neonatol 2021; 118:274–81. doi: 10.1159/000515415
- Davidson JM, Ferguson J, Ivey E, et al. A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants [published online ahead of print, 2020]. J Perinatol. doi: 10.1038/s41372-020-0694-1
- Asbagh PA, Zarkesh MR, Nili F, et al. Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants: A randomized clinical trial. Tehran Univ Med J 2015; 73(2).
- Herrman K, Bose C, Lewis K, et al. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child: Fetal Neonatal Ed 2009; 94(1):F48–50.
- Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010; 30(4):241–52.
- Semberova J, Sirc J, Miletin J, et al. Spontaneous closure of patent ductus arteriosus in infants ≤ 1500 g. Pediatr 2017; 140(2).
- Goyal R, Goyal D, Longo LD, et al. Microarray gene expression analysis in ovine ductus arteriosus during fetal development and birth transition. Pediatr Res 2016; 80(4):610–8.
- Hamrick SE, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant. Pediatr 2020; 146(5).
- Olsson KW, Jonzon A, Sindelar R. A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22–27 weeks gestational age. Crit Care Res Pract 2012; 2012:715265.
- Kumar J, Dutta S, Sundaram V, et al. Platelet transfusion for PDA closure in preterm infants: A randomized controlled trial. Pediatr 2019; 143(5):e20182565.
- Kahvecioglu D, Erdeve O, Akduman H, et al. Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in prematurity. Pediatr Neonatol 2018; 59(1):53–7.